MML INVESTORS SERVICES, LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 701059 SPRINGFIELD, MA

Position in APLS

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

+$0 QoQ

Shares Held

9,504

-30.3% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

18 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MML INVESTORS SERVICES, LLC holds $86,570,832 across 61 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	38,907	$19,326,274
2	REGN	Regeneron Pharmaceuticals, Inc.	18,117	$11,296,674
3	ARGX	Argenx SE	6,825	$6,332,030
4	EXEL	Exelixis, Inc.	73,531	$4,000,821
5	INSM	INSMED Inc	32,823	$3,499,588
6	ALNY	Alnylam Pharmaceuticals, Inc.	9,949	$2,994,947
7	JAZZ	Jazz Pharmaceuticals plc	11,712	$2,822,240
8	RPRX	Royalty Pharma plc	49,942	$2,800,247

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	9,504	-30.3%	Shares	Defined	2026-05-04
2024-09-30	—	13,631	-10.0%	Shares	Defined	2024-11-15
2024-06-30	—	15,150	+23.2%	Shares	Defined	2024-08-14
2024-03-31	—	12,296	+21.4%	Shares	Defined	2024-05-14
2023-12-31	—	10,128	+21.0%	Shares	Defined	2024-02-14
2023-09-30	—	8,369	+13.2%	Shares	Defined	2023-11-14
2023-06-30	—	7,393	+19.2%	Shares	Defined	2023-08-14
2023-03-31	—	6,202	+53.9%	Shares	Defined	2023-05-12
2022-12-31	—	4,030	-4.8%	Shares	Defined	2023-02-13
2022-09-30	—	4,231	-46.4%	Shares	Defined	2022-11-14
2022-03-31	—	7,892	+0.0%	Shares	Defined	2022-05-13
2021-12-31	—	7,891	-1.0%	Shares	Defined	2022-02-14
2021-09-30	—	7,970	+4.6%	Shares	Defined	2021-11-15
2021-06-30	—	7,616	+0.1%	Shares	Defined	2021-08-13
2021-03-31	—	7,610	+0.4%	Shares	Defined	2021-05-14
2020-12-31	—	7,580	0.0%	Shares	Defined	2021-02-12
2020-09-30	—	7,580	0.0%	Shares	Defined	2020-11-13
2020-06-30	—	7,580	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.